Cardio Diagnostics Holdings, Inc. (CDIO) stock
CDIONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIOW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$1.60−0.05 (-3.03%)
Close on Nov 20, 2026Market cap $4.74MP/E –Yield –
Cardio Diagnostics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Cardio Diagnostics's shares outstanding was 3M at Jun 30, 2026. For fiscal 2025 it was 2M, up 95.4% from the year before. The highest annual figure on record is 2M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2M | +95.4% |
| FY2024 | Dec 31, 2024 | 1M | +112.0% |
| FY2023 | Dec 31, 2023 | 0M | +310.8% |
| FY2022 | Dec 31, 2022 | 0M | +165.4% |
| FY2021 | Dec 31, 2021 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 3M | +125.2% |
| Q1 FY2026 | Mar 31, 2026 | 3M | +248.7% |
| Q4 FY2025 | Dec 31, 2025 | 2M | +141.7% |
| Q1 FY2025 | Mar 31, 2025 | 2M | +140.0% |
| Q4 FY2024 | Dec 31, 2024 | 1M | +107.3% |
| Q3 FY2024 | Sep 30, 2024 | 1M | +105.3% |
| Q2 FY2024 | Jun 30, 2024 | 1M | +120.7% |
| Q1 FY2024 | Mar 31, 2024 | 1M | +120.8% |
| Q4 FY2023 | Dec 31, 2023 | 1M | +250.5% |
| Q3 FY2023 | Sep 30, 2023 | 0M | +181.8% |
| Q2 FY2023 | Jun 30, 2023 | 0M | – |
| Q1 FY2023 | Mar 31, 2023 | 0M | – |
| Q2 FY2022 | Jun 30, 2022 | 0M | – |
| Q1 FY2022 | Mar 31, 2022 | 0M | – |
See a number that looks wrong?